Deepak Fertilisers & Petrochemicals Corp Ltd Q4 FY2025 Concall Summary

Key Takeaways

• Strategy validated in P&L, valuation gap persists: Revenue grew 28% YoY in Q4, led by an 86% surge in the CNB business, yet management expressed perplexity that the sum of its three performing businesses is not being fully valued by the market.
• Margin story is a mix shift, not a deterioration: Consolidated EBITDA margin dipped to 18% in Q4 as the high-growth, lower-margin Fertilizer business dominated the mix, while the TAN and CNB segments individually expanded margins.
• Two major projects on track for H2 FY26: The Gopalpur TAN plant (75% complete) and Dahej Nitric Acid plant (48% complete) are both expected to commission in the second half of FY26, setting the stage for a step-change in capacity.
• Debt to peak before new assets contribute: Gross debt is expected to reach approximately INR 5,000 crores by the end of FY26, with deleveraging to begin only after the new facilities start contributing meaningfully to cash flow.
• What to watch next quarter: The pace of volume ramp-up at the new Gopalpur and Dahej plants post-commissioning, the trajectory of deleveraging from peak debt, and any improvement in IPA margins as the specialty product line gains traction.

The Valuation Puzzle

Management sees a disconnect between the company's financial performance and its market valuation, arguing that the combined strength of its three businesses is not being recognized.

• Sum-of-parts undervalued: The Chairman noted that the totality of the three businesses, all performing well, is being valued less than what a single part might command, calling this a source of perplexity.
• Strategy execution validated: Management believes its strategy is now being validated and revalidated directly in the P&L and financial outcomes, pointing to the 28% YoY revenue growth and 390 bps full-year EBITDA margin expansion as proof.
• Disclosure gap acknowledged: An analyst requested more detailed segmental disclosure of each business's underlying moving parts and profitability. Management acknowledged the request but gave no commitment on timing, stating only that it is "a matter of time" before more detail is provided.

Sailesh Mehta: "The perplexment has been that how is it that the sum of the parts, meaning the totality of the 3 businesses which are doing so well, somewhere is not getting valued as much as one part is getting valued."

Crop Nutrition Business (CNB) — The Growth Engine

The CNB segment delivered one of its strongest quarters ever, driving the bulk of consolidated revenue growth and crossing a significant volume milestone for the full year.

• Q4 revenue surge: CNB business grew 86% YoY, making it the primary driver of the 28% consolidated revenue growth.
• Croptek volume doubled: The Croptek product line more than doubled its volume during the quarter, contributing to the segment's breakout performance.
• Full-year milestone crossed: CNB volumes crossed the 0.1 crore metric ton mark for FY25, reflecting sustained demand momentum.
• Freight cost drag: The increase in other expenses was driven by CNB business growth, which carries very high freight output, a structural feature that will persist as the segment scales.
• Kharif season optimism: Management is optimistic for the upcoming kharif season, supported by forecasts of an above-normal monsoon and a targeted approach across cotton, soybean, paddy, and corn through the Mahadhan brand.

Technical Ammonium Nitrate (TAN) — Capacity-Constrained, Demand-Rich

TAN performance remains strong, but volume growth has been suboptimal due to nitric acid capacity constraints rather than any demand weakness. The B2C shift is improving pricing power.

• Sequential volume growth: Q4 TAN volume grew 13% sequentially, with LDAN growing 11% YoY, sustaining positive momentum into FY26.
• Capacity constraint, not demand: Volume growth has been limited to the 1-2% range over the last three years due to nitric acid capacity bottlenecks, not a lack of demand.
• Demand tailwind intact: India's TAN demand is growing at 6-7% annually, adding roughly 1 lakh ton of demand each year. Management expects new capacity to be absorbed as ramp-ups are gradual and imports will remain necessary.
• B2C shift improving pricing: 18% of TAN sales now go directly to end consumers, up from intermediary-based sales. The TCO model enables value-based pricing by positioning the company as a productivity partner rather than a commodity supplier.
• Debottlenecking provides near-term relief: Some debottlenecking of TAN and nitric acid capacity completed towards the end of H1 and beginning of H2 last year will support additional volume in FY26, with growth expected to be slightly better than 2-3%.

Subhash Anand: "This industry, the TAN demand itself is growing 6% to 7% Y-o-Y. That itself is, if we say roughly around 1 lakh ton is getting added in the demand every year. So if you just put these 2 numbers in place and the new capacity, which is coming up, the ramp-up doesn't happen on day 1."

Industrial Chemicals — Mixed Signals

The segment faced a near-term earnings dip from an IPA plant shutdown, while nitric acid volumes grew strongly and the downstream demand picture remains constructive.

• IPA shutdown impact: Q4 segment earnings declined due to a plant shutdown for process enhancement and productivity improvement, which has now been completed. Chemical EBIT margins fell to 23% versus 27-31% in prior quarters.
• IPA margin pressure: Near-term margin pressures persist due to industry oversupply and weak acetone prices, though the specialty product line is gaining steady market traction.
• Nitric acid volume growth: Nitric acid volumes grew 29% YoY in Q4, and the product remains well positioned with improving downstream demand from TAN.
• Ammonia pricing dynamics: Ammonia prices remained broadly at similar levels last year barring one quarter. The benefit of gas price reduction is not yet visible due to contract lags, but the long-term Equinor contract kicks in during FY26.

Capital Projects & The FY27 Leap

Two major projects are progressing toward H2 FY26 commissioning, with management framing FY26-27 as a potential record year when all levers become fully operational.

• Gopalpur TAN project: 75% complete, commissioning expected in H2 FY26. This will add significant TAN capacity to a market that management describes as net short on supply.
• Dahej Nitric Acid project: 48% complete, also expected to commission in H2 FY26, addressing the nitric acid bottleneck that has constrained TAN volume growth.
• Target ROCE of 18-20%: Both new projects are expected to deliver healthy ROCE of 18% to 20%, with first-year utilization targeted at 70% and 80-85% needed to achieve target returns.
• FY26-27 as the inflection: Management described FY26-27 as a potential record year for the Mining Chemicals business, with Gopalpur, the Dahej new plant, and the new gas contract all fully operational simultaneously.
• Balance sheet strengthened: Subsidiary DMSL raised INR 800 crores via convertible debentures in Q1 FY26, and Deepak Fertilisers injected INR 400 crores via OCD into Mahadhan to strengthen its balance sheet for the Gopalpur capital expansion.

Subhash Anand: "That's where all the levers, whether it's Gopalpur, whether it's Dahej new plant or whether it's a new gas contract, all will be fully operational at that time, and we will be in the new leap, I call it."

Guidance & Commitments

Key Metrics